Cargando…
Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism
Recently we showed that pharmacological blockade or genetic deficiency of arginase-2 confers kidney protection in diabetic mouse models. Here we tested whether the protective effect of arginase inhibition is nitric oxide synthase-3 (eNOS)-dependent in diabetic nephropathy. Experiments were conducted...
Autores principales: | You, Hanning, Gao, Ting, Cooper, Timothy K., Morris, Sidney M., Awad, Alaa S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783645/ https://www.ncbi.nlm.nih.gov/pubmed/23760286 http://dx.doi.org/10.1038/ki.2013.215 |
Ejemplares similares
-
Arginase-2 Mediates Diabetic Renal Injury
por: Morris, Sidney M., et al.
Publicado: (2011) -
The Involvement of Arginase and Nitric Oxide Synthase in Breast Cancer Development: Arginase and NO Synthase as Therapeutic Targets in Cancer
por: Avtandilyan, Nikolay, et al.
Publicado: (2018) -
Homoarginine ameliorates diabetic nephropathy independent of nitric oxide synthase‐3
por: Wetzel, Michael D., et al.
Publicado: (2021) -
Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages
por: Rath, Meera, et al.
Publicado: (2014) -
Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury
por: Awad, Alaa S., et al.
Publicado: (2015)